A Phase 1b/2, Open-Label, Randomized Study of Sorafenib With or Without BIIB002 in Subjects With Advanced Hepatocellular Carcinoma

  • Johnson, Philip (Principal Investigator)

Project Details

Short titleA Phase 1b/2, Open-Label, Randomized Study of Sorafenib With or Without BIIB002 in Subjects With Advanced Hepatocellular Carcinoma
StatusFinished
Effective start/end date1/01/10 → 31/08/12

Funding

  • Queen Elizabeth Hospital Birmingham